[Ip-health] Original text of Kenya/Switzerland draft resolution on "Areas for early implementation"

[thiru@cptech.org]

The bottom of the document says:  Draft 17.01.2007, 16.00 hrs

xx plenary meeting xx May 2007 xxxxxx

---------------------

Public health, innovation, essential health research and intellectual
property rights: towards a global strategy and plan of action =96 Areas for
early implementation

The Executive Board,

Having considered the report on the progress made by the Intergovernmental
Working Group on Public health, Innovation, and Intellectual Property at
its first session, and the suggestions made by some Member States of
possible areas for early implementation as set out in the Progress Report
of the Secretariat (Footnote 1: See document EB120/INF.DOC./1)

RECOMMENDS to the Sixtieth World Health Assembly the adoption of the
following resolution:

The sixtieth World Health Assembly,

Having considered the report of the Commission on Intellectual Property
Rights, Innovation and Public Health and its recommendations;

Recalling resolution WHA 59.24, that established an intergovernmental
working group open to all interested Member States to draw up a global
strategy and plan of action in order to provide a medium-term framework
based on the recommendations of the Commission;

Having considered the report of the progress made by the Intergovernmental
Working Group on Public health, Innovation, and intellectual property at
its first session, and the appended list of possible points for early
implementation;

Bearing in mind that resolution WHA59.24 requests the above-mentioned
working group to report to the Sixtieth World Health Assembly through the
Executive Board, giving particular attention to areas for early
implementation action;



Aware of the need to act quickly to address effectively the growing burden
of diseases and conditions disproportionately affecting developing
countries, particularly those affecting women and children, including an
upsurge in noncommunicable diseases;

Aware of the need to start without any delay necessary actions which
foster the future implementation of the global strategy and action plan;

Bearing in mind that these preliminary actions for early implementation
shall not prejudge or limit the content of the future global strategy and
plan of action;

Noting that the Secretariat is already undertaking work in certain areas
for early implementation identified by the Working Group and desiring
scaling up of these activities;

 1. WELCOMES the progress made by the Intergovernmental Working Group on
Public health, Innovation, and intellectual property as reflected in the
Report of the Secretariat; (Footnote 2: Implementation of resolutions:
progress reports: EB120-35 Add.1.)



2. RECOMMENDS Member States



(1) to contribute actively to the development of a global strategy and
plan of action by the Intergovernmental Working Group on Public health,
Innovation, and intellectual property,



(2) to report on a voluntarily basis to the WHO on actions taken on
recommendations of the Commission on Intellectual Property Rights,
Innovation and Public Health;



3. URGE the Director General

(1) to identify gaps in the current coverage of research and development
of medicines and vaccines for diseases that disproportionately affect
developing countries, taking into account other work under way in this
field;

(2) to bring together academics, small and large companies in
pharmaceuticals and biotechnology, governments in the form of aid donors
or medical research councils, foundations, public-private partnerships,
international institutions (such as GFATM, UNITAID, GAVI etc.), and
patient and civil society groups for a standing forum to enable more
organized sharing of information and greater coordination between the
various players in the field of research and development of medicines and
vaccines for diseases that disproportionately affect developing countries;

(3) to promote partnerships to make compound libraries more accessible to
identify potential compounds to address diseases affecting developing
countries;

(4) to promote, with other relevant organisations, patent pools of
upstream technologies that may be useful to foster innovation which
addresses diseases that disproportionately affect developing countries;

(5) to strengthen the clinical trials and regulatory infrastructure in
developing countries, in particular in sub-Saharan Africa, including the
improvement of ethical review standards;

(6) to support developing countries to establish, implement or strengthen
national programmes for health research;

(7) to support countries to seek through patenting and licensing policies,
while respecting international obligations, to maximize the availability
of innovations, including research tools and platform technologies, for
the development of products of relevance to public health, particularly to
conditions prevalent in developing countries;

(8) to collaborate with relevant stakeholders to enhance the
sustainability of public-private partnerships;

(9) to continue to monitor, from a public health perspective, the impact
of intellectual property rights, and other factors, on the development of
new products as well as access to medicines and other health-care products
in developing countries;

(10) to report in the context of the adoption of a global strategy and
plan of action, to the Sixty-first World Health Assembly, through the
Executive Board, on the implementation of this resolution.